Lexatumumab
Product Specifications
CAS Number
845816-02-6
Target
Apoptosis
Related Pathways
Apoptosis
Purity
>95%
Bioactivity
Lexatumumab (GHS-ETR 2) is a human excitatory monoclonal antibody targeting TRAIL receptor 2 that has anticancer activity and induces apoptosis in malignant mesothelioma. Lexatumumab can be used to study malignant pleural mesothelioma (MPM) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15183310 1 Vial
Lentiviral mouse Cdc25c shRNA (UAS) - Lentiviral mouse Cdc25c shRNA (UAS, GFP) plasmid
Ask
View Details